Zosano Pharma Corp Operating Income
Zosano Pharma Corp reported Operating Income of -$33.32 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-05-13
- Zosano Pharma Corp operating income (loss) for the quarter ending 2022-03-31 was -$33.32M.
- Zosano Pharma Corp operating income (loss) for the quarter ending 2021-12-31 was -$6.92M.
- Zosano Pharma Corp operating income (loss) for the quarter ending 2021-09-30 was -$8.60M.
- Zosano Pharma Corp operating income (loss) for the quarter ending 2021-06-30 was -$7.97M.
- Zosano Pharma Corp operating income (loss) for fiscal 2021 was -$31.53M.
- Zosano Pharma Corp operating income (loss) for fiscal 2020 was -$32.76M.
- Zosano Pharma Corp operating income (loss) for fiscal 2019 was -$37.20M.
- Zosano Pharma Corp operating income (loss) for fiscal 2018 was -$35.38M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$33.32M 10-Q · filed 2022-05-13 | -$40.23M derived: sum of 2 quarters · filed 2022-05-13 | -$48.83M derived: sum of 3 quarters · filed 2022-05-13 | -$56.80M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$15.51M derived: sum of 2 quarters · filed 2022-03-17 | -$23.48M derived: sum of 3 quarters · filed 2022-03-17 | -$31.53M 10-K · filed 2022-03-17 |
| 2021-09-30 | -$8.60M 10-Q · filed 2021-11-10 | -$16.57M derived: sum of 2 quarters · filed 2021-11-10 | -$24.61M 10-Q · filed 2021-11-10 | -$32.55M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$7.97M 10-Q · filed 2021-08-10 | -$16.02M 10-Q · filed 2021-08-10 | -$23.96M derived: sum of 3 quarters · filed 2022-05-13 | -$32.48M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$8.05M 10-Q · filed 2022-05-13 | -$15.98M derived: sum of 2 quarters · filed 2022-05-13 | -$24.51M derived: sum of 3 quarters · filed 2022-05-13 | -$32.21M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$16.46M derived: sum of 2 quarters · filed 2022-03-17 | -$24.16M derived: sum of 3 quarters · filed 2022-03-17 | -$32.76M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$8.53M 10-Q · filed 2021-11-10 | -$16.23M derived: sum of 2 quarters · filed 2021-11-10 | -$24.82M 10-Q · filed 2021-11-10 | -$33.57M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$7.70M 10-Q · filed 2021-08-10 | -$16.29M 10-Q · filed 2021-08-10 | -$25.04M derived: sum of 3 quarters · filed 2021-08-10 | -$34.60M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$8.60M 10-Q · filed 2021-05-12 | -$17.34M derived: sum of 2 quarters · filed 2021-05-12 | -$26.90M derived: sum of 3 quarters · filed 2021-05-12 | -$36.31M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$8.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$18.30M derived: sum of 2 quarters · filed 2021-03-11 | -$27.71M derived: sum of 3 quarters · filed 2021-03-11 | -$37.20M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$9.56M 10-Q · filed 2020-11-13 | -$18.96M derived: sum of 2 quarters · filed 2020-11-13 | -$28.45M 10-Q · filed 2020-11-13 | -$38.70M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$9.41M 10-Q · filed 2020-08-06 | -$18.89M 10-Q · filed 2020-08-06 | -$29.14M derived: sum of 3 quarters · filed 2020-08-06 | -$37.40M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | -$9.49M 10-Q · filed 2020-05-14 | -$19.74M derived: sum of 2 quarters · filed 2020-05-14 | -$27.99M derived: sum of 3 quarters · filed 2020-05-14 | -$36.80M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$10.25M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$18.50M derived: sum of 2 quarters · filed 2020-03-13 | -$27.31M derived: sum of 3 quarters · filed 2020-03-13 | -$35.38M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$8.25M 10-Q · filed 2019-11-14 | -$17.06M derived: sum of 2 quarters · filed 2019-11-14 | -$25.13M 10-Q · filed 2019-11-14 | -$32.48M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$8.80M 10-Q · filed 2019-08-14 | -$16.87M 10-Q · filed 2019-08-14 | -$24.22M derived: sum of 3 quarters · filed 2019-08-14 | -$31.94M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$8.07M 10-Q · filed 2019-05-14 | -$15.42M derived: sum of 2 quarters · filed 2019-05-14 | -$23.14M derived: sum of 3 quarters · filed 2019-05-14 | -$29.69M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$7.35M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | -$15.07M derived: sum of 2 quarters · filed 2019-03-25 | -$21.62M derived: sum of 3 quarters · filed 2019-03-25 | -$28.37M 10-K · filed 2019-03-25 |
| 2017-09-30 | -$7.72M 10-Q · filed 2018-11-15 | -$14.27M derived: sum of 2 quarters · filed 2018-11-15 | -$21.02M 10-Q · filed 2018-11-15 | -$28.47M derived: sum of 4 quarters · filed 2018-11-15 |
| 2017-06-30 | -$6.55M 10-Q · filed 2017-08-10 | -$13.30M 10-Q · filed 2018-08-09 | -$20.75M derived: sum of 3 quarters · filed 2018-08-09 | -$27.89M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$6.75M 10-Q · filed 2018-05-15 | -$14.20M derived: sum of 2 quarters · filed 2018-05-15 | -$21.33M derived: sum of 3 quarters · filed 2018-05-15 | -$27.58M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$14.59M derived: sum of 2 quarters · filed 2018-03-12 | -$20.84M derived: sum of 3 quarters · filed 2018-03-12 | -$28.63M 10-K · filed 2018-03-12 |
| 2016-09-30 | -$7.13M 10-Q · filed 2017-11-09 | -$13.38M derived: sum of 2 quarters · filed 2017-11-09 | -$21.18M 10-Q · filed 2017-11-09 | -$28.36M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$6.25M 10-Q · filed 2017-08-10 | -$14.05M 10-Q · filed 2017-08-10 | -$21.23M derived: sum of 3 quarters · filed 2017-08-10 | -$29.58M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | -$7.80M 10-Q · filed 2017-05-09 | -$14.98M derived: sum of 2 quarters · filed 2017-05-09 | -$23.33M derived: sum of 3 quarters · filed 2017-05-09 | -$30.02M derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | -$7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$15.53M derived: sum of 2 quarters · filed 2017-03-01 | -$22.22M derived: sum of 3 quarters · filed 2017-03-01 | -$26.37M 10-K · filed 2017-03-01 |
| 2015-09-30 | -$8.35M 10-Q · filed 2016-11-09 | -$15.03M derived: sum of 2 quarters · filed 2016-11-09 | -$19.18M 10-Q · filed 2016-11-09 | -$22.74M derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | -$6.69M 10-Q · filed 2016-08-10 | -$10.84M 10-Q · filed 2016-08-10 | -$14.39M derived: sum of 3 quarters · filed 2016-08-10 | -$17.50M derived: sum of 4 quarters · filed 2016-08-10 |
| 2015-03-31 | -$4.15M 10-Q · filed 2016-05-12 | -$7.71M derived: sum of 2 quarters · filed 2016-05-12 | -$10.81M derived: sum of 3 quarters · filed 2016-05-12 | -$14.20M derived: sum of 4 quarters · filed 2016-05-12 |
| 2014-12-31 | -$3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | -$6.66M derived: sum of 2 quarters · filed 2016-03-29 | -$10.04M derived: sum of 3 quarters · filed 2016-03-29 | -$12.61M 10-K · filed 2016-03-29 |
| 2014-09-30 | -$3.11M 10-Q · filed 2015-11-10 | -$6.49M derived: sum of 2 quarters · filed 2015-11-10 | -$9.06M 10-Q · filed 2015-11-10 | |
| 2014-06-30 | -$3.38M 10-Q · filed 2015-08-13 | -$5.95M 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | -$2.57M 10-Q · filed 2015-05-12 |